18 Programs

  • Defining the Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer — Issue 1

    Explore program
    • August 2025 0.5 ABIM MOC, ABS MOC, CME 20min
      • E
      Erika Hamilton
  • Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 8

    Explore program
    • May 2025 0.5 ABIM MOC, ABS MOC, CME 13min
      • R
      Rinath M Jeselsohn
  • Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 7

    Explore program
    • May 2025 0.5 ABIM MOC, ABS MOC, CME 17min
      • R
      Rinath M Jeselsohn
  • Optimizing the Selection of First-Line Therapy for Patients with Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement

    Explore program
    • April 2025 1.25 ABIM MOC, ABS MOC, CME 57min
      • J
        Justin F Gainor, MD
      Justin F Gainor
    • April 2025 0.75 ABIM MOC, ABS MOC, CME 31min
      • J
        Justin F Gainor, MD
      Justin F Gainor